![Loïc Vincent](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 245 363 $ op 31-05-2026
Loïc Vincent currently works at Korro Bio, Inc., as Chief Scientific Officer from 2025.
Dr. Vincent also formerly worked at Affini-T Therapeutics, Inc., as Chief Scientific Officer.
Dr. Vincent received his doctorate degree from Université de Rouen Normandie.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,13% | 16-06-2026 | 18.297 ( 0,13% ) | 245 363 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|
| Bedrijven | Functie | Einde |
|---|---|---|
Affini-T Therapeutics, Inc.
 Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 2 |
|---|---|
Université de Rouen Normandie
 Université de Rouen Normandie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
